Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06315829 · ClinicalTrials.gov registry record

Artificial Intelligence-based Video Analysis to Detect Infantile Spasms

A clinical trial of Infantile Spasms, sponsored by Johns Hopkins University.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT06315829: Recruiting study of Infantile Spasms, sponsored by Johns Hopkins University.

NCT06315829 is a study of Infantile Spasms that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06315829, a study of Infantile Spasms, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Infantile spasms are a type of seizure linked to developmental issues. Unfortunately, they are often misdiagnosed, causing delays in treatment. The purpose of this study is to develop a computer program that can reliably differentiate infantile spasms from similar, yet benign movements in videos. This computer program will learn from videos taken by parents of study participants. Quickly recognizing and treating infantile spasms is crucial for ensuring the best developmental outcomes.

Primary Outcome

Proportion of true positives which the model classified correctly in the test dataset.

Conditions Studied

Interventions

  • DEVICE Spasm Vision

Study Locations (1)

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-08-26
Est. Completion 2026-05
Johns Hopkins University

1,448 total trials

What NCT06315829 shows while recruiting

NCT06315829 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Infantile Spasms appearing as the primary indexed condition, and to 1 intervention - of which Spasm Vision is the first listed.

NCT06315829 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06315829 about?

NCT06315829 is a clinical study titled "Artificial Intelligence-based Video Analysis to Detect Infantile Spasms". Infantile spasms are a type of seizure linked to developmental issues. Unfortunately, they are often misdiagnosed, causing delays in treatment. The purpose of this study is to develop a computer program that can reliably differentiate infantile spasms from similar, yet benign movements in videos. Th...

What is the current status of trial NCT06315829?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-08-26. Estimated completion is 2026-05.

What conditions does trial NCT06315829 study?

This clinical trial studies the following conditions: Infantile Spasms.

What interventions are being tested in trial NCT06315829?

The interventions under investigation include: Spasm Vision (DEVICE).

Who is sponsoring clinical trial NCT06315829?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06315829 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infantile Spasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06315829, the US trial registry maintained by the National Library of Medicine. NCT06315829 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.